Ischemic heart disease Board decisions

The veteran's claims for higher disability ratings for CAD and PTSD were denied. The claims for prostatitis and TDIU were remanded.

The appeals for service connection for various heart conditions were dismissed due to the veteran's death.

The Board remanded the veteran's claim for service connection of coronary artery disease, including due to anthrax shots. The decision was based on the need to correct errors and consider new evidence, including the PACT Act.

The veteran's claims for an earlier effective date for shin splints were denied. Service connection for tinnitus and headaches was granted, while claims for coronary artery disease and diverticulitis were remanded.

The Board dismissed claims for higher ratings for diabetic peripheral neuropathy and denied higher ratings for several other conditions. It remanded decisions on TDIU and an effective date for Dependents' Educational Assistance.

The veteran's appeal for a higher rating for service-connected coronary artery disease (CAD) was granted. The Board assigned an initial 60 percent rating effective February 13, 2023.

The Board denied an increased initial disability rating for the veteran's service-connected heart condition, maintaining it at 30%. The decision was based on the evidence showing the veteran's heart disability did not manifest in a workload between 3 and 5 METs.

The appeal for COPD was denied. The claims for eye injury and non-obstructive CAD were remanded for readjudication, with service connection for non-obstructive CAD granted under the PACT Act.

The Board denied service connection for all claimed conditions due to lack of evidence of herbicide agent exposure during the Veteran's service.

The Board remanded the veteran's claims for service connection for a right ankle condition, ischemic heart disease (IHD), and low back condition. The Board found errors in the previous decisions and ordered new examinations and opinions.

The veteran's service connection for bipolar II disorder was granted with an effective date of June 10, 2021. Service connection for tinnitus, hypertension, and heart disorder were denied.

The Board remanded the veteran's claim for service connection of a heart disability, including ischemic heart disease and coronary artery disease. The decision was based on the need to obtain additional medical records and verify herbicide agent exposure.

The veteran's claims for service connection for obstructive sleep apnea, respiratory disorder, hypertension, heart disorder, and diabetes mellitus were granted. The claim for an increased rating for major depressive disorder was denied, and the claim for total disability rating due to individual unemployability was remanded.

The Board denied service connection for left eye pain and a heart disorder because there is no evidence linking these conditions to the veteran's military service.

The Board remanded the Veteran's claims for a higher disability rating and TDIU due to missing records and inadequate examinations.

The veteran's PTSD rating was not increased beyond 50%, but a 60% rating for NSTEMI with CAD was granted effective November 9, 2020. The veteran also qualified for TDIU benefits.

The veteran's claims for increased ratings for hypertension, urinary incontinence, and swallowing difficulties were denied. The effective dates for service connection for transient ischemic attack, urinary incontinence, and swallowing difficulties were granted as of August 10, 2022. The claim for service connection for heart disability and other issues were remanded.

The appeal for service connection of a heart condition, including atrial fibrillation, is remanded. The VA will consider new evidence and obtain a medical opinion on the cause of the heart disability.

The veteran's appeal for service connection of multiple conditions was dismissed because the veteran withdrew the appeal.

The appeal for service connection of sleep apnea is remanded. The Board needs more information on how the veteran's service-connected conditions may have caused or worsened obesity and sleep apnea.